On this episode of our podcast, Conversations with B’nai B’rith, health policy and legal expert Zachary Baron speaks with B’nai B’rith CEO Dan Mariaschin about the Inflation Reduction Act (IRA) and its impact on Medicare and prescription drugs.

Baron, director of the Health Policy and the Law Initiative at the O’Neill Institute (at Georgetown University Law Center), discusses key aspects of the IRA and its repercussions on Medicare and prescription drugs. He breaks down the legislation, exploring its effects on drug pricing and delves into the ongoing legal battles involving the IRA.

Watch the interview on YouTube and Facebook.